QVIDTVM Management LLC grew its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 75.8% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 458,866 shares of the medical instruments supplier's stock after buying an additional 197,803 shares during the quarter. DENTSPLY SIRONA accounts for about 8.7% of QVIDTVM Management LLC's investment portfolio, making the stock its 5th biggest position. QVIDTVM Management LLC owned 0.23% of DENTSPLY SIRONA worth $12,417,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently modified their holdings of the business. UMB Bank n.a. boosted its position in DENTSPLY SIRONA by 430.3% in the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier's stock valued at $25,000 after buying an additional 753 shares during the period. Capital Performance Advisors LLP bought a new stake in shares of DENTSPLY SIRONA during the third quarter valued at approximately $27,000. LRI Investments LLC boosted its holdings in shares of DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier's stock valued at $31,000 after purchasing an additional 564 shares during the period. Rothschild Investment LLC bought a new position in DENTSPLY SIRONA in the second quarter worth approximately $32,000. Finally, Kennebec Savings Bank bought a new stake in DENTSPLY SIRONA during the 3rd quarter valued at $35,000. 95.70% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
XRAY has been the topic of a number of recent research reports. Evercore ISI dropped their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating on the stock in a research report on Tuesday, October 8th. Leerink Partnrs downgraded shares of DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a research report on Thursday, November 7th. StockNews.com cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Tuesday, November 19th. Barrington Research cut their price objective on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an "outperform" rating on the stock in a report on Friday, November 8th. Finally, Needham & Company LLC lowered their target price on DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating for the company in a report on Friday, October 25th. Seven analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $29.50.
Read Our Latest Stock Report on DENTSPLY SIRONA
DENTSPLY SIRONA Stock Performance
XRAY stock traded down $0.32 during trading on Tuesday, reaching $19.20. The company had a trading volume of 1,224,046 shares, compared to its average volume of 3,128,266. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA Inc. has a twelve month low of $17.21 and a twelve month high of $37.60. The company has a market cap of $3.82 billion, a price-to-earnings ratio of -9.26, a price-to-earnings-growth ratio of 1.84 and a beta of 1.02. The firm has a 50-day simple moving average of $23.12 and a 200-day simple moving average of $24.99.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business had revenue of $951.00 million for the quarter, compared to the consensus estimate of $939.10 million. During the same quarter in the previous year, the business earned $0.49 EPS. The company's quarterly revenue was up .4% compared to the same quarter last year. As a group, sell-side analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.
About DENTSPLY SIRONA
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Featured Articles
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.